Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |